

Important advances occurred in the field of movement disorders in 2025. The surge of wet biomarkers over the past few years has now led to biological definitions of neurodegenerative diseases. However, the main breakthroughs have been driven by technological advances in neuroimaging, neuromodulation, cell and gene therapy, digital biomarkers, deep learning, and artificial intelligence.
Neurology
|11th Mar, 2026
|The Lancet
Neurology
|11th Mar, 2026
|The Lancet
Neurology
|11th Mar, 2026
|The Lancet
Neurology
|11th Mar, 2026
|The Lancet
Neurology
|11th Mar, 2026
|The Lancet
Neurology
|11th Mar, 2026
|The Lancet
Neurology
|11th Mar, 2026
|The Lancet